VanEck Pharmaceutical ETF
127 hedge funds and large institutions have $684M invested in VanEck Pharmaceutical ETF in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less funds holding
Funds holding: 133 → 127 (-6)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
92% less call options, than puts
Call options by funds: $3.32M | Put options by funds: $41.4M
Holders
127
Holding in Top 10
1
Calls
$3.32M
Puts
$41.4M
Top Buyers
| 1 | +$141M | |
| 2 | +$39.3M | |
| 3 | +$35.4M | |
| 4 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$28.6M |
| 5 |
Jane Street
New York
|
+$23.8M |
Top Sellers
| 1 | -$111M | |
| 2 | -$12.4M | |
| 3 | -$10.4M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.13M |
| 5 |
Two Sigma Investments
New York
|
-$4.6M |
